DOTA-ALB-02
DOTA-ALB-02 is an albumin-bound FAP inhibitor (FAPI) ligand. DOTA-ALB-02 labeled with 177Lu has a high FAP-binding affinity and enhanced tumor uptake and retention with a significant tumor/nontarget ratio. DOTA-ALB-02 can be used for PET/CT and SPECT/CT imaging of cancers, especially late-stage cancers[1].
Product Specifications
UNSPSC
12352100
Target
FAP
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
O=C(NCCCCC(C(NC1=CC=CC2=C1N=CC=C2C(NCC(N3CC(C[C@H]3C#N)(F)F)=O)=O)=O)NC(CCCC4=CC=C(I)C=C4)=O)CCOCCOCCOCCOCCOCCOCCNC(CN5CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC5)=O
Molecular Formula
C64H91F2IN12O18
Molecular Weight
1481.38
References & Citations
[1]Wu T, et al. Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites. Mol Cancer Ther. 2025 Aug 1;24 (8) :1186-1196.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6718204 1.0 µg DNA
Gsta4 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 
